ArticleNature communications2023

Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia.

Hanlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.